Indian standalone business is expected to continue delivering healthy performance on the back of resilient domestic demand, stable pricing, and growth-focused capital allocation toward the non-cyclical business, adds the brokerage.
Indian standalone business is expected to continue delivering healthy performance on the back of resilient domestic demand, stable pricing, and growth-focused capital allocation toward the non-cyclical business, adds the brokerage.
<iframe src="https://hindustansphere.com/embed/cluster/2bbaf5a4de6f4eca05680718855071796c5420d6" width="100%" height="320" style="border:0;max-width:680px" loading="lazy" title="Tata Chemicals Q1 Review: Strong India Business, Weak Overseas Operations Keep Motilal Oswal Neutral — Check Target Price"></iframe>
